←
Mathias Heikenwälder212 posts
Mathias Heikenwälder avatar

Mathias Heikenwälder

@CancerInflam

Univ. Prof. Director The M3 Research Center UKT Division Head German Cancer Research Center Chronic Inflammation and Cancer Views are my own

◷ Joined January 2016▧ 8 Photos and videos
DKFZ avatar
⟳ Mathias Heikenwälder retweeted
DKFZ@DKFZ·8h

Twelve researchers who conduct research at the DKFZ or lead joint bridge departments with the DKFZ have reached the very top in 2026: They rank among the top 1 percent of the world’s most-cited researchers in their respective fields. 👏 t1p.de/symxo

Mathias Heikenwälder avatar
Mathias Heikenwälder@CancerInflam·Sep 2

It was a plasure and honor to write this review with Suchira Gallage, Olivier Govaere, Quentin Anstee, Gerald Shulman and Frank Tacke. We start to understand more and more about the most prevalent liver disease - still much to be learned-on pathogenesis, prevention and therapy.

A state-of-the science 5 ★ review of MASH (fatty liver with inflammation, nonalcoholic). Awareness of this important, highly prevalent, often undiagnosed condition has increased in recent years, and now the interventions to go after it have blossomed (Figure) @Nature @CancerInflam @GallageSuchira nature.com/articles/s41586-0…

Post attachment
EASL Education avatar
⟳ Mathias Heikenwälder retweeted
EASL Education@EASLedu·Aug 4

Ready to lead your own research group? 🔬 The science may be familiar but what about managing a team, securing funding, building a research programme and planning a sustainable career?🫣 The next episode of #TalkLiverToMe explores what research independence really looks like. ℹ️easl.eu/event/what-nobody-te… @C_V_Schneider @CancerInflam @RautouE @Mandorf1 @IsraelsenMads @ZanettoAlberto #LiverX

1:47
Mathias Heikenwälder avatar
Mathias Heikenwälder@CancerInflam·Jun 24

Very proud to have written this EASL postion paper togehter with so many fantastic people - as well as to have done this #talklivertoME episode with Rui and Suchira - always a pleasure.

New episode of #TalkLivertoMe is now available! 🎙️ 🐁Mice, organoids, precision-cut liver slices, human-based systems… which models best reflect human #SLD? Or maybe the better question is: Which model is best for the endpoint you’re investigating?🤔 Read the position papar and listen below. 📰journal-of-hepatology.eu/art… 📺easlcampus.eu/tltm/episode-1… 🎙️open.spotify.com/episode/524… 🎙️podcasts.apple.com/us/podcas… @JHepatology #LiverX

Post attachment
EASL Education avatar
⟳ Mathias Heikenwälder retweeted
EASL Education@EASLedu·Jun 24

New episode of #TalkLivertoMe is now available! 🎙️ 🐁Mice, organoids, precision-cut liver slices, human-based systems… which models best reflect human #SLD? Or maybe the better question is: Which model is best for the endpoint you’re investigating?🤔 Read the position papar and listen below. 📰journal-of-hepatology.eu/art… 📺easlcampus.eu/tltm/episode-1… 🎙️open.spotify.com/episode/524… 🎙️podcasts.apple.com/us/podcas… @JHepatology #LiverX

Post attachment

New Talk Liver to Me podcast coming up this Wednesday! 🐭 Can a mouse truly model human steatotic liver disease? And does the perfect preclinical model even exist? In the upcoming episode, we will explore the new EASL position paper on preclinical SLD models with Rui Castro, Mathias Heikenwälder and Suchira Gallage. Together, they will discuss the challenges of modelling MASLD, MetALD, and ALD, and what researchers and clinicians should know when interpreting preclinical data. 👉 Read more easl.eu/event/chasing-the-pe… 📰 Access the position paper that will be discussed! pubmed.ncbi.nlm.nih.gov/4219… @GallageSuchira @CancerInflam @RuiCastroHD

2:18
Mohammad Rahbari avatar
⟳ Mathias Heikenwälder retweeted
Mohammad Rahbari@MoRahbari·May 30

Proud of the new work by my colleagues @GallageSuchira and @CancerInflam: journal-of-hepatology.eu/art… An important guideline on how to use preclinical models to study the pathobiogy of fatty liver disease. @EASLnews @DKFZ @EASLedu @JHepatology

Mathias Heikenwälder avatar
Mathias Heikenwälder@CancerInflam·May 27

This will become extremely useful to the scientific community. What mouse model to use in order to mimic steatotic liver disease (SLD), which in vitro models, what to take care of, what to analyse - we have integrated recommendations and introduced the state of the art models.

Derek A Mann avatar
⟳ Mathias Heikenwälder retweeted
Derek A Mann@derekamann1·May 8

This will be an excellent scientific session at EASL 2026 congress on HCC in the background of metabolic liver disease. It’s an early morning session on 30th May but is going to be well worth the early morning wake up! @EASLnews @CancerInflam @Valeriechew29

Post attachmentPost attachment